High-dose chemotherapy with autologous stem cell transplantation for multiple myeloma: what predicts the outcome? Experience from a developing country.

MLA

Kumar, L., et al. “High-Dose Chemotherapy with Autologous Stem Cell Transplantation for Multiple Myeloma: What Predicts the Outcome? Experience from a Developing Country.” Bone Marrow Transplantation, vol. 43, no. 6, Mar. 2009, pp. 481–89. EBSCOhost, https://doi.org/10.1038/bmt.2008.343.

APA

Kumar, L., Ghosh, J., Ganessan, P., Gupta, A., Hariprasad, R., & Kochupillai, V. (2009). High-dose chemotherapy with autologous stem cell transplantation for multiple myeloma: what predicts the outcome? Experience from a developing country. Bone Marrow Transplantation, 43(6), 481–489. https://doi.org/10.1038/bmt.2008.343

Chicago

Kumar, L., J. Ghosh, P. Ganessan, A. Gupta, R. Hariprasad, and V. Kochupillai. 2009. “High-Dose Chemotherapy with Autologous Stem Cell Transplantation for Multiple Myeloma: What Predicts the Outcome? Experience from a Developing Country.” Bone Marrow Transplantation 43 (6): 481–89. doi:10.1038/bmt.2008.343.